Search neutralizing antibodies that block infection of cells by the human genetic variants of HIV-1 subtypes A, B and CRF63_02A1
Abstract
We studied serum from HIV-infected individuals with progressive form of the disease is not on the panel of infectious HIV-1 isolates. The study revealed neutralizing properties of the weaker suppression isolates CRF63_02A1 recombinant form of HIV-1, whereas sera from individuals infected with CRF63_02A1, the vast majority of the studied isolates us.
About the Authors
N. A. Blednyh
State Research Center of Virology and Biotechnology "Vector"
Russian Federation
Russian Federation
N. V. Unagaeva
State Research Center of Virology and Biotechnology "Vector"
Russian Federation
Russian Federation
F. O. Mirdzhamalova
GBUZ VAT "Center for Prevention and Control of AIDS and Infectious Diseases"
Russian Federation
Russian Federation
N. Y. Chernousova
GBUZ VAT "Center for Prevention and Control of AIDS and Infectious Diseases"
Russian Federation
Russian Federation
N. M. Gashnikova
State Research Center of Virology and Biotechnology "Vector"
Russian Federation
Russian Federation
References
1. Гашникова Н.М., Сафронов П.Ф., Никонорова Ю.В. и др. Изучение свойств изолятов CRF02_AG ВИЧ-1, циркулирующих на территории Новосибирской области // Журн. микробиологии, эпидемиологии и иммунобиологии. - 2011. - № 3. - С. 38-43
2. Baryshev P.B., Bogachev V.V., Gashnikova N.M. Near full-lenght genome characterization of a newly derived unique recombinant form AG HIV-1 circulating in Siberia// Retrovirology. - 2012. - 9 (Suppl 1). - P. 28. Published online. doi: 10.1186/1742-4690-9-S1-P28., 2014
3. Baryshev P. B., Bogachev V. V., Gashnikova N. M. The HIV-1 Genetic Diversity in Russia: CRF63_02A1, a New HIV-1 Genetic Variant Spreading in Siberia. AIDS Research and Human Retroviruses. - 2013. - V. 29, doi:10.1089/aid.2013.0196.
4. Bonsignori M., Munir A., Liao H.-X. HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design // Trends in Microbiology, Nov.r 2012, Vol. 20, No. 11
5. Euler Z., Schuitemaker H. Cross reactive broadly neutralizing antibodies: timing is everything // Frontiers in Immunology. July2012. Vol. 3.
6. Gashnikova N. M., Bogachev V. V., Baryshev P. B. et al. A Rapid Expansion of HIV-1 CRF63_02A1 Among Newly Diagnosed HIV-Infected Individuals in the Tomsk Region, Russia // AIDS RESEARCH AND HUMAN RETROVIRUSES. - 2015. - V. 31, Num. 4.
7. Kwong P. D., Mascola J. R, Nabel G. J. et al. The changing face of HIV vaccine research. // Journal of the International AIDS Society. - 2012. V 15:17407
8. Verkoczy L., Kelsoe G., Barton F. Haynes HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development. - May 2014. - V. 10.
9. Walker L. M., Phogat S.K., Chan-Hui P.Y. et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target // Science. - Oct.2009. - V. 326. - Р. 285 - 288.
Review
For citations:
Blednyh N.A., Unagaeva N.V., Mirdzhamalova F.O., Chernousova N.Y., Gashnikova N.M. Search neutralizing antibodies that block infection of cells by the human genetic variants of HIV-1 subtypes A, B and CRF63_02A1 . Far Eastern Journal of Infectious Pathology. 2015;(28):67-69. (In Russ.)
Views:
79
Email this article 